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ThrombosisCytosolic-free Ca2+ plays a crucial role in blood platelet function and is essential for thrombosis and hemostasis.
Therefore, cytosolic-free Ca2+ concentration is tightly regulated in this cell. TRPC6 is expressed in platelets, and
an important role for this Ca2+ channel in Ca2+ homeostasis has been reported in other cell types. The aim of this
work is to study the function of TRPC6 in platelet Ca2+ homeostasis. The absence of TRPC6 resulted in an 18.73%
decreased basal [Ca2+]c in resting platelets as compared to control cells. Further analysis conﬁrmed a similar
Ca2+ accumulation in wild-type and TRPC6-deﬁcient mice; however, passive Ca2+ leak rates from agonist-
sensitive intracellular stores were signiﬁcantly decreased in TRPC6-deﬁcient platelets. Biotinylation studies indi-
cated the presence of an intracellular TRPC6 population, and subcellular fractionation indicated their presence on
endoplasmic reticulummembranes. Moreover, the presence of intracellular calcium release in platelets stimulat-
edwith 1-oleoyl-2-acetyl-sn-glycerol further suggested a functional TRPC6 population located on the intracellu-
lar membranes surrounding calcium stores. However, coimmunoprecipitation assay conﬁrmed the absence of
STIM1–TRPC6 interactions in resting conditions. This ﬁndings together with the absence of extracellular Mn2+
entry in restingwild-type platelets indicate that the plasmamembrane TRPC6 fraction does not play a signiﬁcant
role in the maintenance of basal [Ca2+]c in mouse platelets. Our results suggest an active participation of the
intracellular TRPC6 fraction as a regulator of basal [Ca2+]c, controlling the passive Ca
2+ leak rate from agonist-
sensitive intracellular Ca2+ stores in resting platelets.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The intracellular free-calcium ion (Ca2+) is the master secondary
messenger in cells, which is involved in many basic cellular functions
[1]. Thus, the cytosolic free-Ca2+ concentration ([Ca2+]c) is tightly
regulated by many intracellular mechanisms of Ca2+ homeostasis.
Blood platelets are small anucleated cell fragments derived from bone
marrow megakaryocytes that, once activated by physiological agonists,
play a key function in mechanisms of thrombosis and hemostasis [2].
The increase of basal [Ca2+]c observed in stimulated platelets triggers
cellular responses that are critical for their activation and function [2].
This [Ca2+]c elevation is achieved by two main mechanisms: discharge
of agonist-sensitive intracellular Ca2+ stores, extracellular Ca2+ inﬂux
through the plasma membrane, or both. Ca2+ mobilization is regulatedction; IP, immunoprecipitated
c artery vascular smoothmuscle
y, University of Extremadura,
: +34 927 257139x51376;
ights reserved.by Ca2+ channels located in membranes separating extracellular and
subcellular compartments, so that depletion of agonist-sensitive intra-
cellular stores is mainly regulated by inositol triphosphate (IP3) recep-
tors in activated platelets, whereas extracellular Ca2+ entry is mainly
regulated by members of the transient receptor potential (TRP) and
the Orai Ca2+ channel family [3,4]. Orai channels and certain members
of the canonical TRP (TRPC) Ca2+ channel subfamily are activated by a
previous depletion of agonist-sensitive intracellular stores through a
mechanism referred to as store-operated Ca2+ entry (SOCE) [4]. Stro-
mal interaction molecule 1 and 2 (STIM1 and 2) are the Ca2+ sensors
located in the membrane of the endoplasmic reticulum (ER) and other
organelles, which participate in this mechanism by detection of de-
creases in their Ca2+ content and migration to the plasma membrane
to interact and to activate TRPC and Orai Ca2+ channels [5]. Moreover,
several TRPC members can be also stimulated and activated by diacyl-
glycerol [6–8], a molecule synthesized by phospholipase C, which is
widely activated during platelet function [4]. In vivo studies using mu-
rine transgenicmodels demonstrated a relevant function of TRPC6 in di-
verse cells, for instance cells of the immune [9,10], nervous [11,12],
vascular [13–19] or digestive systems [20] and kidney [21]. Previous
studies demonstrated that mouse platelets and megakaryocytes, their
cellular precursors, only express RNA transcripts for TRPC(1,6) and
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TRPC(1,3,4,5,6), TRPM(2,7) and TRPV(1,2,4) [6,25–33].
The resting [Ca2+]c, normallymaintained in the range of 10–100nM,
is the result of passive Ca2+ movements towards the cytosol mostly
compensated by the activity of plasma membrane and endosomal
Ca2+-ATPases, and sometimes the mitochondria. The maintenance of
a low [Ca2+]c is an essential physiological mechanism to avoid the acti-
vation of Ca2+-dependent events. In human platelets, resting [Ca2+]c
has been reported to be altered in certain pathologies, such as diabetes
mellitus [34], leading to hyperaggregability and hyperactivity. Hence,
we have explored the role of TRPC6 in the maintenance of resting
[Ca2+]c in blood platelets using a murine transgenic model lacking the
TRPC6 channel.
2. Material and methods
2.1. Reagents
1-Oleoyl-2-acetyl-sn-glycerol (OAG), apyrase (grade VII), acetyl-
salicylic acid, anti-actin polyclonal antibody, bovine serum albumin
(BSA), calcium chloride, citric acid, ethyleneglycol-bis(β-aminoethyl)-N,
N,N′,N′-tetraacetic acid (EGTA), ethylenedinitrilotetraacetic acid (EDTA),
glucose, HEPES, manganese(II) chloride tetrahydrate, sodium citrate,
thapsigargin (TG), Trizma® hydrochloride and Trizma® base were
purchased from Sigma–Aldrich (Germany). 1,2-Bis [2-aminophenoxy]
ethane-N,N,N′,N′-tetraacetic acid tetrakis [acetoxymethyl ester] (BAPTA)
was purchased from Molecular Probes®, Life Technologies Ltd (Paisley,
UK). Isoﬂurane (ISOFLO®) was purchased from Esteve Veterinaria
(Barcelona, Spain). Complete EDTA-free protease inhibitor tablets were
purchased from Roche Pharma AG (Germany). Rabbit anti-mTRPC6 poly-
clonal antibody was purchased from Alomone Labs (Jerusalem, Israel).
Mouse anti STIM1 antibody was from BD Transduction Laboratories
(Frankin Lakes, NJ, USA). Horseradish peroxidase-conjugated anti-rabbit
IgG and anti-mouse antibodies were purchased from Jackson Immuno-
Research (PA, USA). Hyperﬁlm ECL was from Amersham (Buckingham-
shire, UK). Protein A-conjugated agarose beads were purchased from
Millipore (CA, USA). Enhanced chemiluminescence detection reagents
and rabbit anti-mouse IgG were from Pierce (Cheshire, UK). Western
blot nitrocellulosemembranes were purchased from Bio-Rad Laborato-
ries (CA, USA). Agarose and ethidium bromide were purchased from
Roth (Germany). EZ-Link Sulfo-NHS-LC-Biotin and streptavidin–
conjugated agarose beads were purchased from Thermo Fisher Scientif-
ic Inc (IL, USA). All other analytical grade reagents were purchased from
Sigma–Aldrich (Germany).
2.2. TRPC6-deﬁcient mouse generation
TRPC6-deﬁcient mice were purchased from Deltagen, Inc. (San
Mateo, CA, USA) through the European Mouse Mutant Archive
(EMMA) network, and theywere generated as follows (Fig. 1): A region
of the murine Trpc6 gene containing the exon four (E4) was subcloned.
The targeting vector was engineered by substitution of 13 nucleotides
located into E4with a selection cassette containing an internal ribosome
entry site,β-galactosidase (lacZ) and the neomycin (Neo) resistant gene
(Fig. 1A). The targeting vector was electroporated into murine embry-
onic stem (ES) cells. Positive ES cell colonies expressing the Neo resis-
tant gene were picked, their DNA was isolated and subsequently
screened by Southern blot using an external probe speciﬁc for the
Trpc6 gene, seeking for those clones that integrated the Trpc6-null allele
into the Trpc6wild-type locus by homologous recombination (targeted
allele) (Fig. 1B). Electroporated ES cell clone #1152 resulted heterozy-
gous for the Trpc6-null allele, and it was microinjected into wild-type
3.5 days old blastocysts to generate chimeric mice. Chimeric mice
were backcrossed with C56Bl6 mice to obtain the ﬁrst generation (F1)
of heterozygous (HT) mice for the Trpc6-null allele. Individuals of the
F1 generation were ﬁnally intercrossed to obtain homozygous micefor the Trpc6-null allele (KO) (Fig. 1C). The disruption of the TRPC6
mRNA transcript translation and the expression of the TRPC6 channel
were later conﬁrmed by western blot using an anti-TRPC6 antibody
(Alomone, Israel) (Fig. 1D). All experiments were conducted on mice
between 8 and 12 weeks of age. Experiments involving animals were
conducted in accordance with the regulations of the local authorities
and were approved by the institutional review boards of all participat-
ing institutions.
2.3. Mouse DNA isolation and PCR genotyping
Mouse genomic DNAwas isolated following Jackson Laboratory's in-
dications. Five square millimetres of ear tissue was digested in 400 μL
DNA lysis buffer (10 mM Tris–HCl, 50 mM NaCl, 25 mM EDTA pH 8.0,
0.5% SDS, 0.5 mg/mL proteinase K, pH 8.0) overnight. SDSwas then pre-
cipitated with 200 μL saturated NaCl and centrifuged for 20–30 min at
16,000×g. 500 μL supernatantwas recovered,mixedwith 1000 μL of ab-
solute ethanol and genomic DNAwas precipitated by centrifugation for
10 min at 16,000 ×g. Genomic DNA pellet was washed once with 1 mL
70% ethanol. The residual ethanol was evaporated avoiding excessive
DNA drying, and the DNA was resuspended overnight in 50 μL TE
(10 mM Tris–HCl, 1 mM EDTA, pH 8.0) at 4 °C.
Theﬂowingprimerswere used to identify thewild-type andknockout
allele: mTRPC6_genot_2F: 5′-atatgcccacatttaagctaggatgaac-3′, mNeo_F:
5′-gggccagctcattcctcccactcat-3′, mTRPC6_genot_R: 5′-agctagatctttgc
ctgctggacag-3′. Two separated PCR reactions (Takara, Japan) were per-
formed with different primer pairs to amplify the wild-type (mTRPC6_
genot_2F and mTRPC6_genot_R, 588 bp) and the knockout allele
(mNeo_F and mTRPC6_genot_R, 408 bp). The PCR program used is:
95 °C, 5 min; 94 °C, 30 s; 60 °C, 30 s; 72 °C, 30 s, 35 cycles; 72 °C,
10min. PCR productswere separated in 1% agarose gel by electrophoresis
and stained with ethidium bromide. 1 cm3 of agarose gel containing the
PCR product was extracted using the PCR NucleoSpin® Extract II kit
(Macherey-Nagel, Germany) and sequenced (STAB-SAIUex, University
of Extremadura, Spain) to conﬁrm the correct ampliﬁcation of the desired
genomic DNA region.
2.4. Blood platelet isolation
Mice were bled under isoﬂurane anesthesia from the retroorbital
plexus according to the recommendations of the local Ethical Commit-
tee. Blood was collected into an Eppendorf tube containing 300 μL acid
citrate dextrose buffer (85 mM sodium citrate, 78 mM citric acid,
111 mM glucose, pH 7.3). Blood was centrifuged in a Galaxy 7D centri-
fuge (VWR International, PA, USA) at 300 ×g for 5 min. The supernatant
was centrifuged again at 100 ×g for 5min to obtain platelet-rich plasma
(prp). Prp was centrifuged at 600 ×g for 5 min in the presence of the
cyclooxygenase inhibitor acetylsalicylic acid (0.1 μg/mL) and the pellet
was resuspended in Ca2+-free Tyrode's buffer (NaCl 137 mM, KCl 2.7
mM, NaHCO3 12 mM, NaH2PO4 0.43 mM, Glucose 0.1%, HEPES 5 mM,
BSA 0.35%, CaCl2 1 mM, MgCl2 1 mM, pH 7.13) containing apyrase
(40 μg/mL).
2.5. Immunoprecipitation and western blotting
Brieﬂy, 500 μL aliquots of washed platelet suspension (2 × 109
cell/mL) were lysed with an equal volume of 2 × RIPA buffer
(316 mM NaCl, 20 mM Tris, 2 mM EGTA, 0.2% SDS, 2% sodium
deoxycholate, 2% triton X-100, 2 mM Na3VO4 and complete EDTA-
free protease inhibitor tablets, pH 7.2). Cell debris was removed by
max. speed centrifugation for 10 min at 4 °C. For immunoprecipita-
tion assay, 1 mL platelet lysates were immunoprecipitated by
incubation with 2 μg of anti-STIM1 antibody and 25 μL of protein
A-conjugated agarose beads overnight at 4 °C on a rocking platform.
Total protein and immunoprecipitated lysates were separated in
8% SDS-PAGE gels and electrophoretically transferred onto
Fig. 1. Characterization of TRPC6-deﬁcientmice and analysis of [Ca2+]c changes and intracellular Ca2+mobilization in isolatedWT andKOplatelets. (A) Targeted disruption strategy of the
murine Trpc6 gene. (B) Southern blot analysis of positive ES cells carrying theNeo resistance gene (ﬁgure kindly providedbyDeltagen©). The selection cassette of the targeted allele inserts
a new BamHI restriction site, which generates a smaller DNA fragment (KO, b4.3 Kb) compared to the wild-type allele (WT, N9.4 Kb), and can be detected by an internal radioactively-
labelled probe. The ES cell clone #1152 resulted heterozygous for the Trpc6-null allele, and it was injected into wild-type blastocyst to generate chimeric mice. (C) Agarose picture of
PCR products. The PCR genotyping strategy conﬁrmed the presence of mice homozygous for the Trpc6 targeted allele (KO) amongmice heterozygous for the targeted allele (HT) and ho-
mozygous for the wild-type allele (WT). (D) Western blot analysis of TRPC6 protein expression in platelets isolated from WT and KO mice as compared to β-actin (actin) (n= 3). (E)
Upper: Representative graph of basal [Ca2+]c records from isolated resting WT (black) and KO (grey) platelets in the presence of 75 μM EGTA. Lower: histograms represent basal
[Ca2+]c values expressed asmean [Ca2+]c ± SEM (n≥ 26); *P b 0.05, Student's t-test. (F) Upper: Representative traces of [Ca2+]c from isolatedWT (black) and KO (grey) platelets before
and after intracellular Ca2+ mobilization stimulated with a mixture of 1 μM TG and 100 nM ionomycin in the presence of 75 μM EGTA. Lower: histograms represent TG + ionomycin-
induced Ca2+ release over basal, estimated as described in Material and methods, and expressed as the mean integral ± SEM (n= 6); (n.s.) Student's t-test, not signiﬁcant.
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blocked with 5% (w/v) BSA in tris-buffered saline (0.05 M Trizma
Base, 0.9% NaCl, pH 8.4) with 0.1% Tween 20 (TBST) overnight.
Immunodetection of TRPC6 was achieved using the speciﬁc anti-
TRPC6 antibody diluted 1:1000 for 2 h at room temperature (RT).Blots were washed three times for 5 min in TBST, subsequently
incubated with a horseradish peroxidase-conjugated secondary
antibody diluted 1:10000 in TBST for 45 min at RT and then exposed
to enhanced chemiluminescence reagents for 4 min. Blots were then
exposed to X-ray ﬁlms.
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Washed platelets (108) were resuspended in biotinylation buffer
(50 mM NaHCO3 and 0.9% NaCl) and surface labelled with 100 μg/mL
sulfo-NHS-LC biotin at RT. Labelling was stopped 30 min after reaction
with 1% NH4Cl and phosphate-buffered saline (PBS, NaCl 137 mM, KCl
2.7 mM, KH2PO4 1.5 mM, Na2HPO4•2H2O 8 mM, pH 7.14) supplement-
ed with 50 μM EDTA and washed two times in PBS/EDTA. Biotinylated
platelets were subsequently lysed in RIPA buffer as described in
western blotting procedures, and protein lysates were incubated with
streptavidin–conjugated agarose beads overnight at 4 °C on a rocking
platform. Biotinylated proteins bound to streptavidin–conjugated aga-
rose beads were isolated by centrifugation and washed three times in
RIPA buffer. Total protein and immunoprecipitated lysates were loaded
and separated in 8% SDS-PAGE and probed as described in western
blotting procedures.2.7. Subcellular fractionation and ER isolation
Platelets were isolated from 10wild-typemice blood andwashed as
described above. Washed platelets were pulled, and ER membranes
were isolated with an ER isolation kit (Sigma, Germany). All the proce-
dure was performed at 4 °C. Brieﬂy, pulled platelets were suspended in
a hypotonic buffer for 20 min, centrifuged at 600 ×g and suspended in
an isotonic buffer. Cell membranes were broken by ultrasound sonica-
tion, and unbroken cells were removed by 10 min centrifugation at
1000 ×g. Mitochondrial fractions were removed from the supernatant
by 15 min centrifugation at 12,000 ×g. The microsomal fraction
containing ER membranes was precipitated and separated from the
supernatant by 1 h at 100,000 ×g ultracentrifugation. Pelleted micro-
somal fraction was washed, resuspended again in isotonic buffer, and
ER membranes were further puriﬁed from this fraction by Optiprep
density gradient separation at 150,000 ×g for 3 h (from top to bottom,
1.6 mL 15%, 0.6 mL 20% mixed microsomal fraction and 0.8 mL 30%
Optiprep). The different fractions were separated by SDS-PAGE and
probed with antibodies against TRPC6. Plasma membrane contamina-
tion in enriched ER fractionswas assessed using an anti-PMCA antibody
(clone 5F10; Pierce, Rockford, IL).2.8. Measurement of [Ca2+]c
Washed platelets were loaded with fura-2 by incubation with
2 μM fura-2/AM for 45 min at 37 °C in the absence of extracellular
Ca2+. Cells were subsequently washed and resuspended in Tyrode's
buffer. Fura-2 was excited at alternate wavelengths of 340 and
380 nm, and the emission ﬂuorescence was recorded at 505 nm
from 600 μL aliquots of magnetically stirred cellular suspension at
37 °C using an RF-5301PC spectrophotometer (Shimadzu Corpora-
tion, Kyoto, Japan). Changes in [Ca2+]c were assessed by the fura-2
340/380 ﬂuorescence ratio according to Grynkiewicz et al. [35]. TG
and iono-induced Ca2+ release was estimated using the integral of
the rise in [Ca2+]c over basal for 3 min after their addition taking a
sample every 1 s and was expressed as nM s [36].
To compare the rate of Ca2+ efﬂux from the agonist-sensitive stores
after treatment of platelets with TG in the absence of extracellular Ca2+,
traces were ﬁtted to the equation: y = Ax + B, where A is the slope of
the curve [37].2.9. Statistical analysis
Analysis of statistical signiﬁcancewas performed using one-way anal-
ysis of variance. For comparisonbetween twogroups, Student's t-testwas
used. p b 0.05 was considered to be signiﬁcant for a difference.3. Results
3.1. TRPC6-deﬁcient mice develop and are apparently normal
We used a murine transgenic model to study the function of TRPC6
in blood platelets. Mice homozygous for the Trpc6-null mutation (KO)
were fertile, developed normally and were apparently healthy (data
not shown) as previously reported for other TRPC6-deﬁcient mice
[19]. Western blot assay conﬁrmed the presence of TRPC6 protein in
platelets obtained from wild-type mice (WT) as previously reported
elsewhere [6] and the absence of TRPC6 in platelets isolated from KO
mice (Fig. 1D).
3.2. TRPC6 participates as a regulator of basal [Ca2+]c in resting platelets
Despite TRPC6 has not been found essential for platelet aggregation,
this channel plays a relevant role in Ca2+ homeostasis in mouse and
human platelets stimulated with agonists [27,38]. In the present
study, we have focused on the role of TRPC6 in resting [Ca2+]c. As
depicted in Fig. 1, KO platelets displayed an 18.73% decreased basal
[Ca2+]c as compared toWT controls in the presence of the extracellular
Ca2+ chelator EGTA (WT: 84.65 ± 5.10 nM; KO: 68.79 ± 3.77 nM; p
b 0.05; n≥ 26) (Fig. 1E), suggesting a participation of TRPC6 in the con-
trol of platelet basal [Ca2+]c. Since a small intracellular fraction of TRPC6
population has been previously shown in other cell models [39,40], we
investigated whether this population exists also in platelets and if they
might be implicated in intracellular Ca2+ mobilization. We performed
biotinylation studies in platelets due to the difﬁculty to perform immu-
nocytochemistry in such a small cell (Fig. 2A). In resting conditions, the
presence of an unbiotinylated TRPC6 fraction in WT platelets (void)
suggested the presence of an intracellular TRPC6 fraction (n = 3),
which might participate in intracellular Ca2+ mobilization. Moreover,
OAG-stimulated (100 μM) WT platelets showed a signiﬁcant Ca2+ re-
lease (2295.07 ± 279.33 nM s; p b 0.05; n = 5) from agonist-
sensitive intracellular stores as compared to vehicle addition in the
presence of EGTA (Fig. 2B), suggestive of a functional machinery in-
volved in store depletion. Western blot of isolated WT platelets after
subcellular membrane fractionation revealed TRPC6 expression in the
ER-enriched fraction (Fig. 2C), strongly suggesting an ER-resident
TRPC6 subpopulation (n= 2). The absence of the plasma membrane-
resident PMCA in this ER fraction indicates the absence of plasma
membrane-resident TRPC6 contamination. Thus, our experimental
results suggest the presence of a functional TRPC6 subpopulation locat-
ed on the membranes of agonist-sensitive intracellular Ca2+ stores,
such as the ER.
In order to establishwhether the absence of TRPC6 has an impact on
agonist-sensitive intracellular Ca2+ stores, the amount of Ca2+ stored in
these intracellular reservoirs was indirectly assessed. For that, intracel-
lularmembraneswere permeatedwith amixture of the sarco/ER Ca2+-
ATPase (SERCA) inhibitor TG and the permeant ionophore ionomycin,
and the amount of Ca2+ passively released to the cytoplasm from the
stores was assessed with fura-2, as the amount of intracellularly re-
leased and stored Ca2+ is directly proportional (Fig. 1F). In the presence
of 1 μMTG, 100 nM ionomycin and 75 μMof the extracellular Ca2+ che-
lator EGTA, the amount of intracellular Ca2+ released to the cytoplasm
was similar in both KO and WT control platelets (WT: 4093.89 ±
277.72 nM s; KO: 4435.61 ± 559.71 nM s; p= 0.4; n= 6), suggesting
that the ability of platelets to accumulate Ca2+ into the agonist-
sensitive intracellular stores was not signiﬁcantly affected in the ab-
sence of TRPC6, which conﬁrms that the different basal [Ca2+]c in WT
and KO platelets was not due to a distinct amount of Ca2+ accumulated
into the agonist-sensitive intracellular stores.
We have further explored the role of TRPC6 expression in the rate of
passive Ca2+ leak from the agonist-sensitive intracellular stores. To in-
vestigate this issue, cells were treated with TG in a Ca2+-free medium
(75 μM EGTA added) to prevent Ca2+ reuptake into agonist-sensitive
Fig. 2. Expression of TRPC6 in plasma and intracellular membranes. (A) Western blot of total cellular protein lysates extracted from biotinylated WT platelets. TRPC6 expression was
detected with an anti-TRPC6 antibody. Left lane represents the biotinylated protein fraction located in the plasma membrane (Plasma Mem). Right lane contains a 10% total volume of
the remaining unbiotinylated protein fraction (Void) (n= 3). (B) Representative graph of [Ca2+]c records from isolated WT platelets in the presence of 100 μM OAG and 75 μM EGTA
(n=5). (C)Western blot analysis of TRPC6 expression inWT platelet plasmamembrane (PlasmaMem) and endoplasmic reticulum (ER) enriched fractions isolated byOptiprep®density
gradient. PMCA-positive lanes represent fractions enriched with plasma membranes (n= 2).
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as described in methods. Interestingly, in platelets from WT mice, the
rate of Ca2+ efﬂux was signiﬁcantly greater than in those from KO
mice (the slope of the curve was 1.88 ± 0.33 nM s−1 in WT and 1.03 ±
0.13 nM s−1 in KO mice; p b 0.05; n = 5). These ﬁndings indicate that
TRPC6 is a leak channel of the agonist-sensitive Ca2+ compartments
that plays a relevant role in the maintenance of the basal [Ca2+]c.3.3. Extracellular Ca2+ does not play a relevant role in the maintenance of
resting [Ca2+]c
We have tested whether the differences observed in basal [Ca2+]c
between WT and KO platelets in the absence of extracellular Ca2+ also
occur in the presence of extracellular Ca2+. As shown in Fig. 3A, resting
KO platelets showed signiﬁcantly decreased basal [Ca2+]c in the pres-
ence of 500 μM Ca2+ as compared to WT controls (WT: 94.94 ± 7.62
nM; KO: 65.93 ± 8.26 nM; p b 0.05; n = 5). However, the resting
[Ca2+]c was not signiﬁcantly different in the absence (open bars) or
presence of 500 μM extracellular Ca2+, both in WT and KO platelets,
which strongly suggest that Ca2+ entry has a minor role, if any, in the
maintenance of basal [Ca2+]c in mouse platelets. To conﬁrm this possi-
bility, 50 μMMn2+ was added to the platelet suspension at rest in the
presence of 500 μMCa2+. Mn2+ entry has been widely used as a surro-
gate for Ca2+ inﬂux given its quenching effect on fura-2 [41]. As
depicted in Fig. 3B, no change in the resting [Ca2+]c (and fura-2 ﬂuores-
cence) was detected upon addition of Mn2+ either in WT or KO plate-
lets, which strongly suggests that Ca2+ inﬂux is undetectable in
resting platelets and conﬁrms that Ca2+ entry is not relevant for the
maintenance of basal [Ca2+]c in mouse platelets. Furthermore, these
ﬁndings indicate that the intracellular rather than the plasma
membrane-resident pool of TRPC6 is responsible for the attenuation in
resting [Ca2+]c in KO platelets.3.4. STIM1 does not control TRPC6 activity in resting conditions
Themolecular player of SOCE, STIM1, has been proposed as a regula-
tor of TRPC6 activitywhen complexedwith Orai1 in stimulated platelets
and other cells [31,42,43]. Thus, we investigated the possibility that
STIM1 regulates TRPC6 activity also in resting conditions (Fig. 3C).
Western blotting studies using an anti-TRPC6 antibody revealed that
TRPC6 does not appear complexed with immunoprecipitated STIM1 in
resting platelets (IP), but remains in the non-immunoprecipitated
fraction (“Non-IP”) (n=3). Thus, the absence of STIM1–TRPC6 interac-
tion in resting platelets suggests that STIM1 does not regulate TRPC6
function in resting conditions.4. Discussion
TRPC6 function has been recently studied in blood platelets using a
murine transgenic model lacking TRPC6 function generated by
Birnbaumer's group [38,44,45]. However, contradictory results were
reported, and its function in platelets is still unclear [46]. In fact, most
studies of TRPC function have found many controversies, suggesting a
complex regulation of these channels and a heterogeneous function in
many cell types. This situation indicates that TRP function should be
studied more in detail. We have used a different murine transgenic
model lacking TRPC6 to study its function platelet Ca2+ homeostasis.
Three different groups have studied TRPC6 function in platelets using
knockout transgenic murine models, and one of them showed experi-
mental data concerning basal [Ca2+]c at resting conditions [38,44,45].
Ramanathan et al. showed a non statistically signiﬁcant decrease of
basal Ca2+ in platelets isolated from a different TRPC6-deﬁcient mouse
strain at resting conditions [38]. Our results showa signiﬁcant 18.73% de-
creased [Ca2+]c in platelets lacking TRPC6 at resting conditions (Fig. 1E).
These differences could be explained by different reasons: 1) The
Fig. 3. Ca2+ entry by TRPC6 is not involved in the control of basal [Ca2+]c. (A) Histograms representing basal [Ca2+]c values from isolated restingWT (black) and KO (grey) platelets in the
presence of 500 μMextracellular Ca2+, as compared to values obtained in the presence of 75 μMEGTA already shown in Fig. 1E (open bars), expressed asmean [Ca2+]c ± SEM (n=5); *P
b 0.05, not signiﬁcant (n.s.), Student's t-test. (B) Representative traces of basal [Ca2+]c records from isolated restingWT (black) and KO (grey) platelets in the presence of 500 μM extra-
cellular Ca2+ before and after addition of 50 μMmanganese (Mn+) (n=4). (C)Western blot of total cellular protein lysates extracted fromWT platelets. Left lane represents the protein
fraction coimmunoprecipitated with an anti-STIM1 antibody (IP). Right lane contains the 5% total volume of the remaining non-coimmunoprecipitated protein fraction (Non-IP). TRPC6
expression was detected with an anti-TRPC6 antibody (n= 3).
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between both murine strains used in both reports. This research group
used amurinemodel bearing a silenced TRPC6 allele generated by inser-
tion of a selection cassette that replaced the exon 7, while our murine
model equally silences TRPC6 but by insertion of the selection cassette
into the exon 4; 2) The different protocols used by both groups before
Ca2+ measurements. Blood platelet isolation requires total absence of
extracellular Ca2+ in order to prevent spontaneous platelet activation.
Thus, platelets are routinely isolated in the absence of extracellular
Ca2+. However, this conditionmight have an impact in platelet Ca2+ ho-
meostasis since there is evidence that the extracellular Ca2+ ([Ca2+]o)
might condition TRPC6 activity [47,48]. Moreover, extracellular Ca2+-
sensing receptor (CaR, also known as CASR) has been found expressed
in platelets [49]. CaR is a surface receptor sensitive to [Ca2+]o, and it
has been found linked to TRPC6 activity in rat neonatal ventricular
myocytes [50]. In order to prevent altered platelet function due to the ab-
sence of extracellular Ca2+ during the isolation procedure, we previously
incubated platelets in the presence of 50 μMextracellular Ca2+ for 5min
at 37 °C before any experiment, which is enough to prevent spontaneous
platelet activation, to avoid any alteration in TRPC6 activity and to allow
the compensation of possible intracellular Ca2+ loss during the isolation
process. We additionally prevented further stimulation of Ca2+ entry
promoted by spontaneous release of second wave agonists, such as
thromboxane andADP, by addition of inhibitors such as the cyclooxygen-
ase inhibitor acetylsalicylic acid and apyrase, respectively. These protocol
differences used as compared to Ramanathan et al., together with a suit-
able increase of number of experiments (n ≥ 26) used due to the small
differences found in basal [Ca2+]c among KO andWT platelets, might ex-
plain these slight differences observed in our study.
Our results indicate the presence of TRPC6 both in the plasmamem-
brane and internal organelles. The fact that similar resting [Ca2+]c were
found in the absence and presence of extracellular Ca2+ indicates that
the plasma membrane pool of TRPC6 is not involved in the attenuatedbasal [Ca2+]c observed in KO platelets, being this attributed to the
TRPC6 expressed in internal stores. This statement is also based on the
reduced Ca2+ leakage rate from the agonist-sensitive stores observed
in KO mice as compared to WT mice. Since the different Ca2+ leak rate
was estimated upon inhibition of SERCA, our results indicate that
TRPC6 is located in agonist-sensitive intracellular stores. The presence
of TRPC6 in ER-enriched membrane fractions after subcellular fraction-
ation, which is negative for the plasma membrane marker PMCA, indi-
cated that this intracellular population is most likely located in the ER.
Thus, our results indicate that TRPC6 might have a basal activity in
resting platelets and suggest that TRPC6 might have a function in
basal [Ca2+]c regulation. Previous evidence found by other groups sup-
ports this idea. For instance, a certain TRPC6 basal activity has been re-
ported by whole cell patch clamp in HEK 293 resting cells [51]. The
research work also demonstrated that the N-linked glycosylation of
TRPC6, which is a mechanism implicated in correct protein folding, is
mostly responsible of this tightly basal TRPC6 activity regulation, since
removal of glycosylation sites by point mutations greatly increases its
basal activity. Another study performed in native rabbit mesenteric
artery vascular smooth muscle cells (VSMCs) showed that TRPC6 func-
tion depends on [Ca2+]c [52]. Patch clamp records showed that angio-
tensin II-induced TRPC6 activity increased ﬁve-fold in the presence of
the intracellular Ca2+ chelator BAPTA compared to untreated cells,
while increased [Ca2+]c inhibited angiotensin II-induced TRPC6 channel
activity in inside-out patches, demonstrating that TRPC6 activity is
sensitive to [Ca2+]c as it should be expected for a mechanism involved
in basal [Ca2+]c regulation. Calmodulin (CaM) has been shown to
interact and negatively regulate TRPC6 [53–55]. This interaction
depends on [Ca2+]c, since high concentrations promote CaM–TRPC6
interactions [56].
In summary, our results provide for the ﬁrst time evidence for a role
of TRPC6 in the maintenance of resting [Ca2+]c as a leak channel most
likely located in agonist-sensitive intracellular Ca2+ compartments.
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